Cargando…

Mecillinam – Reversion of Resistance and How to Test It

Detalles Bibliográficos
Autor principal:	Frimodt-Moller, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605362/ https://www.ncbi.nlm.nih.gov/pubmed/28864161 http://dx.doi.org/10.1016/j.ebiom.2017.08.023

Ejemplares similares

Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review
por: Jansåker, Filip, et al.
Publicado: (2018)

Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae
por: List, Karoline Knudsen, et al.
Publicado: (2022)

Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient
por: Nielsen, Karen Leth, et al.
Publicado: (2019)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine
por: Thulin, Elisabeth, et al.
Publicado: (2017)

The urine microbiome – Contamination or a novel paradigm?
por: Frimodt-Møller, Niels
Publicado: (2019)

Letter to the editor: Antimicrobial resistance data and treatment guidelines – challenges in the context of urine samples and mecillinam testing
por: Abu Sin, Muna, et al.
Publicado: (2023)

Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam
por: Fuchs, Frieder, et al.
Publicado: (2021)

In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022)

Counting Replication Origins to Measure Growth of Pathogens
por: Charbon, Godefroid, et al.
Publicado: (2020)

Retracted: In vivo mecillinam resistance in Escherichia coli after pivmecillinam treatment of a urinary tract infection
Publicado: (2019)

Reviving the role of mecillinam against extended spectrum beta-lactamase producing enterobacterales
por: Kaleem, Fatima, et al.
Publicado: (2022)

Low-dose irradiation for reversing immunotherapy resistance: how to translate?
por: Ochoa-de-Olza, Maria, et al.
Publicado: (2022)

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease
por: Persson, Frederik, et al.
Publicado: (2019)

Ibuprofen versus mecillinam for uncomplicated cystitis - a randomized controlled trial study protocol
por: Vik, Ingvild, et al.
Publicado: (2014)

Upregulation of PBP1B and LpoB in cysB Mutants Confers Mecillinam (Amdinocillin) Resistance in Escherichia coli
por: Thulin, Elisabeth, et al.
Publicado: (2019)

The mecillinam resistome reveals a role for peptidoglycan endopeptidases in stimulating cell wall synthesis in Escherichia coli
por: Lai, Ghee Chuan, et al.
Publicado: (2017)

Pharmacokinetic/Pharmacodynamic Determination of Systemic MIC Breakpoints for Intermittent, Extended, and Continuous Infusion Dosage Regimens of Mecillinam
por: Koumaki, Vasiliki, et al.
Publicado: (2023)

Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
por: Marcusson, Linda L., et al.
Publicado: (2009)

1617. Mecillinam susceptibility against Enterobacterales isolated from urinary tract infections from US patients in 2018
por: Hawser, Stephen, et al.
Publicado: (2020)

Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20
por: Kresken, Michael, et al.
Publicado: (2022)

Targeting Ceramide Synthesis to Reverse Insulin Resistance
por: Schmitz-Peiffer, Carsten
Publicado: (2010)

1043. Activity of Mecillinam Against Enterobacterales Isolates Collected From Patients With Urinary Tract Infections (UTIs) in the USA During 2019
por: Hawser, Stephen, et al.
Publicado: (2021)

Asymptomatic Bacteriuria (ABU) in Elderly: Prevalence, Virulence, Phylogeny, Antibiotic Resistance and Complement C3 in Urine
por: Leihof, Rikke Fleron, et al.
Publicado: (2021)

1428. Increased Consumption of Pivmecillinam in Primary Care for Uncomplicated Urinary Tract Infection (uUTI) Is Not Associated With Increased Resistance Rates
por: Larsen, Anders Rhod, et al.
Publicado: (2021)

High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli
por: Søraas, Arne, et al.
Publicado: (2014)

Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer
por: Huang, Jinmei, et al.
Publicado: (2022)

Antibody tests for diagnosing COVID-19: how relevant are they?
por: Shey, Muki Shehu, et al.
Publicado: (2020)

Ceramide and Insulin Resistance: How Should the Issue Be Approached?
por: Górski, Jan
Publicado: (2012)

Can reversal of RYGB also reverse hypoglycemia?
por: Arora, Ipsa, et al.
Publicado: (2018)

Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus.
por: Monnet, D L, et al.
Publicado: (2001)

ON NO—The Continuing Story of Nitric Oxide, Diabetes, and Cardiovascular Disease
por: Bøtker, Hans Erik, et al.
Publicado: (2013)

Fatal Attraction Evaded: How Pathogenic Bacteria Resist Cationic Polypeptides
por: Ganz, Tomas
Publicado: (2001)

In vitro tests for drug resistance in Plasmodium falciparum
por: Wernsdorfer, Walther H.
Publicado: (2012)

2547. Targeting penicillin-binding protein 2 (PBP2) to treat metallo-beta-lactamase (MBL)-producing Klebsiella pneumoniae: Mecillinam as an American Ninja Warrior
por: Klem, Jack F, et al.
Publicado: (2023)

Use of diagnostic tests and the appropriateness of the treatment decision in patients with suspected urinary tract infection in primary care in Denmark – observational study
por: Córdoba, Gloria, et al.
Publicado: (2018)

Effect of point-of-care susceptibility testing in general practice on appropriate prescription of antibiotics for patients with uncomplicated urinary tract infection: a diagnostic randomised controlled trial
por: Holm, Anne, et al.
Publicado: (2017)

Structures of Reverse Transcriptase Pre- and Post-Excision Complexes Shed New Light on HIV-1 AZT Resistance
por: Scott, Walter A.
Publicado: (2011)

HIV drug resistance testing – The quest for Point-of-Care
por: Noguera-Julian, Marc
Publicado: (2019)

The strains recommended for use in the bacterial reverse mutation test (OECD guideline 471) can be certified as non-genetically modified organisms
por: Sugiyama, Kei-ichi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i2v8pa1u9iaqkg2gt208a8s8v6